Search

GENENTECH'S TECENTRIQ IMPRESSES AGAIN IN LATE-STAGE KIDNEY CANCER TRIAL

The study met its co-primary endpoint of investigator-assessed progression-free survival in people whose disease expressed the PD-L1...

Every New FDA Drug Approval in 2017

EVERY NEW FDA DRUG APPROVAL IN 2017

2017 was a busy year for the FDA. With 46 approvals, the year far outpaced the 22 approvals in 2016. We've already shown you every...

 
 
 
 
 
 

GENENTECH'S HEMLIBRA DATA CONTINUES TO WOW AT ASH

One of the most important points about Hemlibra's approval, beyond its significant efficacy is the positive impact it will have one...

 
 
 
Bio Roundup: Migraine Data, Cancer Drug Combos, Azar Hearing & More

BIO ROUNDUP: MIGRAINE DATA, CANCER DRUG COMBOS, AZAR HEARING & MORE

A pair of migraine drugs made a splash in biotech news this week with published data suggesting that they can reduce the frequency...

 
 
 
Roche Gains Ground on Rivals With Drug Combo's Success in Lung Cancer

ROCHE GAINS GROUND ON RIVALS WITH DRUG COMBO'S SUCCESS IN LUNG CANCER

Roche/Genentech reported this morning that its cancer immunotherapy drug, atezolizumab , has succeeded in a clinical study that could...

FDA Approves Genentech Hemophilia Drug, But Adds Safety Warning

FDA APPROVES GENENTECH HEMOPHILIA DRUG, BUT ADDS SAFETY WARNING

The FDA has approved a Genentech drug meant to prevent or reduce bleeding in hemophilia A patients who have developed an immune response...

 
 
 
Halozyme Inks $105M Bristol-Myers Partnership, Expands Roche Deal

HALOZYME INKS $105M BRISTOL-MYERS PARTNERSHIP, EXPANDS ROCHE DEAL

Halozyme Therapeutics has turned a method of delivering a drug more conveniently into partnerships with several large pharmaceutical...

 
 
 
 
 
 
Merck Drug Shows No Life-Extending Benefit in Head-and-Neck Cancer

MERCK DRUG SHOWS NO LIFE-EXTENDING BENEFIT IN HEAD-AND-NECK CANCER

The first immunotherapy approved in the U.S. to treat head and neck cancer has failed a big test, but it's unclear if the FDA will...

In Maine, Making Cancer DNA Tests Free-And Asking Tough Questions

IN MAINE, MAKING CANCER DNA TESTS FREE-AND ASKING TOUGH QUESTIONS

Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck's...

 
 
 

FDA GREEN LIGHTS GENENTECH???S ACTEMRA FOR GIANT CELL ARTERITIS

Life Sciences Jobs ...